Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Pharm Res. 2014 Mar 19;31(9):2490–2502. doi: 10.1007/s11095-014-1345-z

Table I. Characterization of nanoemulsion formulations.

Formulations Hydrodynamic diameter of nanoemulsion droplets Zeta Potential (mV) Pt encapsulation efficiency
Size (nm) PDI
Blank nanoemulsion 140 ± 1.6 0.04 -49 ± 10 -
Myrisplatin/ceramide nanoemulsion (non-targeted) 141 ± 3.0 0.10 -54 ± 9 100%
Myrisplatin/ceramide nanoemulsion (EGFR targeted) 146 ± 4.0 0.10 -59 ± 10 100%

The values are shown as Avg ± SD, n=3.